PLUS THERAPEUTICS Inc. (NASDAQ: PSTV)
$1.87
+0.1000 ( +5.65% ) 38.2K
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Market Data
Open
$1.87
Previous close
$1.77
Volume
38.2K
Market cap
$10.78M
Day range
$1.79 - $1.93
52 week range
$0.97 - $3.21
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
def | Proxies and info statements | 13 | Jul 10, 2024 |
ars | Annual reports | 1 | Jul 10, 2024 |
8-k | 8K-related | 11 | Jun 07, 2024 |
8-k | 8K-related | 20 | Jun 04, 2024 |
8-k | 8K-related | 11 | May 20, 2024 |
8-k | 8K-related | 12 | May 15, 2024 |
10-q | Quarterly Reports | 49 | May 15, 2024 |
4 | Insider transactions | 1 | May 10, 2024 |
4 | Insider transactions | 1 | May 10, 2024 |
4 | Insider transactions | 1 | May 10, 2024 |